Cytokine CCL5 and Receptor CCR5 Axis in Glioblastoma Multiforme

BACKGROUND: Glioblastoma is the most frequent and aggressive brain tumour in humans with median survival from 12 to 15 months after the diagnosis. This is mostly due to therapy resistant glioblastoma stem cells in addition to intertumour heterogeneity that is due to infiltration of a plethora of hos...

Descripción completa

Detalles Bibliográficos
Autores principales: Kranjc, Miha Koprivnikar, Novak, Metka, Pestell, Richard G., Lah, Tamara T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884928/
https://www.ncbi.nlm.nih.gov/pubmed/31747383
http://dx.doi.org/10.2478/raon-2019-0057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884928/
https://www.ncbi.nlm.nih.gov/pubmed/31747383
http://dx.doi.org/10.2478/raon-2019-0057

Ejemplares similares